SCHEMBL23959214

SCHEMBL23959214

Cc1ccc2c(c1)c1cc(C)ccc1n2-c1c(C)cc(-c2cnc3nc(-c4ccccc4)c(-c4ccccc4)n3c2)cc1C

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 12/20 0.45
▸ AKT2 P31751 12/20 0.45
▸ ROCK2 O75116 1/20 0.36
▸ PIM1 P11309 1/20 0.36
▸ GSK3B P49841 1/20 0.36
▸ LMNA P02545 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ DHODH Q02127 1/20 0.33
▸ NR1I2 O75469 1/20 0.32
▸ EGFR P00533 1/20 0.32
▸ ADRA2A P08913 1/20 0.32
▸ ADORA3 P0DMS8 1/20 0.32
▸ TBXA2R P21731 1/20 0.32
▸ PTGS2 P35354 1/20 0.32
▸ OPRD1 P41143 1/20 0.32
▸ PDE4D Q08499 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23959210 0.88 AKT1 (0.46) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959209 0.87 AKT1 (0.51) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959101 0.84 AKT1 (0.47) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959119 0.83 AKT1 (0.47) AKT1AKT2
SCHEMBL23959278 0.82 AKT1 (0.46) AKT1AKT2LMNAKDM4EALDH1A1
SCHEMBL23959301 0.79 AKT2 (0.46) AKT1AKT2MAPT
SCHEMBL23959212 0.78 AKT1 (0.48) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959491 0.78 AKT1 (0.54) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959240 0.76 AKT1 (0.53) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959252 0.75 AKT1 (0.43) AKT1AKT2LMNAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192901-B2 Nitrogen-containing heterocyclic organic compound and organic electroluminescent device SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-12-07 — — US disclosed
US-20210332066-A1 NITROGEN-CONTAINING HETEROCYCLIC ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-10-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192901-B2 Nitrogen-containing heterocyclic organic compound and organic electroluminescent device H1-10, H1-0, OR10J3 AKT1 1176/4885AKT2 1711/4885ROCK2 2074/4885
US-20210332066-A1 NITROGEN-CONTAINING HETEROCYCLIC ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE H1-10, H1-0, OR10J3 AKT1 1176/4885AKT2 1711/4885ROCK2 2074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback